ZIM
MDGL icon

ZPR Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

ZPR Investment Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-296
Closed -$23K – 35
2015
Q2 		$23K Buy
+296
New +$24.8K 0.02% 31

Other funds holding MDGL

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ZPR Investment Management's MDGL Position: Q3 2015 in Review

ZPR Investment Management sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2015, closing a stake of 296 shares — an estimated $23K sold.

ZPR Investment Management first reported a position in MDGL in Q2 2015 and held it in 1 quarter. The position peaked at $23K in Q2 2015. 84 funds tracked by Wall St. Rank hold MDGL as of Q3 2015.

  • ZPR Investment Management reported no remaining Madrigal Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • ZPR Investment Management sold 296 Madrigal Pharmaceuticals shares in Q3 2015, an estimated $23K.
  • ZPR Investment Management first reported a position in Madrigal Pharmaceuticals in Q2 2015 and held it in 1 quarter.
  • ZPR Investment Management's Madrigal Pharmaceuticals position peaked at $23K in Q2 2015.
  • 84 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2015.

Based on ZPR Investment Management's 13F filing for Q3 2015, filed 13 Nov 2015.